Endocrinology & metabolism
Hormones & metabolism clinical trials
Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We’re tracking 7,616 recruiting studies in this area right now.
By phase
- Not applicable5,344
- Phase 2606
- Phase 1557
- Phase 3418
- Phase 4318
- Phase 1/Phase 2288
- Phase 2/Phase 385
Top conditions
- Obesity618
- Ovarian Cancer337
- Pancreatic Cancer287
- Type 2 Diabetes275
- Diabetes192
- Diabetes Mellitus182
- Diabetes Mellitus, Type 2171
- Hypertension138
- Type 1 Diabetes131
- Metabolic Syndrome127
- Obesity & Overweight125
- Breast Cancer111
- Cardiovascular Diseases105
- Overweight105
- Amyotrophic Lateral Sclerosis102
- Pancreas Cancer91
- Colorectal Cancer90
- Thyroid Cancer87
Leading sponsors
- Mayo Clinic87
- Novo Nordisk A/S64
- University of Colorado, Denver53
- Assistance Publique - Hôpitaux de Paris52
- M.D. Anderson Cancer Center42
- Eli Lilly and Company41
- Massachusetts General Hospital41
- IRCCS Azienda Ospedaliero-Universitaria di Bologna40
- National Taiwan University Hospital40
- Johns Hopkins University38
Where studies are running
- California521
- Maryland180
- Alabama176
- Arizona170
- Florida166
- Texas159
- Massachusetts150
- New York144
- Colorado115
- Pennsylvania113
Recruiting studies7,616 total
- NCT06706791RecruitingPhase 4
Empagliflozin for heart failure & diabetes: quality of life study
This trial tests whether a diabetes medicine called empagliflozin can improve the quality of life for people who have both chronic heart failure with a weak heart pump and type 2 diabetes. It compares the effects of adding empagliflozin to your current treatments.
Karachi, SindhAges 40–70 - NCT06842433Recruiting
Personalized nutrition study for weight and health
This study tests a personalized nutrition program based on your unique data. It aims to help improve health and weight through tailored diet advice.
WageningenAges 40–70 - NCT06881485Recruiting
Medication with or without a special diet for weight regain after bariatric surgery
This study tests if a combination of two drugs (naltrexone and bupropion) with or without a very low-calorie ketogenic diet can help people who have regained weight after gastric bypass or sleeve gastrectomy. It may offer a non-surgical option to manage weight regain.
Leuven, Vlaams-BrabantAges 18 years+ - NCT06890169Recruiting
One-stop telehealth program for weight and diabetes
This trial tests a telehealth program that helps people lose weight and manage type 2 diabetes and fatty liver disease at the same time. It's a one-stop remote clinic that combines medical advice, nutrition, and lifestyle support.
SingaporeAges 21–70 - NCT06888544Recruiting
High-intensity interval training for bone health in older women
This trial tests whether high-intensity interval training (short bursts of intense exercise) can improve bone health in women aged 60 to 74 with osteopenia (low bone density, but not osteoporosis). Participation involves supervised exercise sessions and bone density measurements.
China, Hong KongAges 60–74 - NCT07272824Recruiting
Digital weight management program for pregnancy and after birth
This trial tests a digital program that helps women manage their weight during and after pregnancy. The program uses an online 'maternity card' and care pathway to provide support.
Turku, FinlandAges 18–50 - NCT07269847Recruiting
Beef-heavy diet study for adults with pre-diabetes
This study tests whether a diet rich in beef can improve metabolic health in adults with pre-diabetes or metabolic syndrome compared to a typical healthy U.S. diet. Eligible participants will follow one of two meal plans for several weeks.
Guelph, Ontario - onAges 18–74 - NCT07278336RecruitingPhase 1
Study of a new drug for advanced ovarian cancer
This trial tests a new drug called ABBV901, given alone or with other anticancer drugs, for people with advanced ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see how well it works and how it affects the body.
Duarte, CaliforniaAges 18 years+ - NCT07271186RecruitingPhase 2
Study of an experimental drug for kidney disease from type 2 diabetes
This study tests an investigational drug called ALN-ANG3 to see if it can help people with diabetic kidney disease. The drug may reduce kidney damage and slow down the loss of kidney function. If you join, you will get the study drug or a placebo (a dummy shot) and be followed by a study doctor.
Huntsville, AlabamaAges 18–80 - NCT07275788RecruitingPhase 1
Study of REGEND003 for type 2 diabetes with kidney disease
This trial tests a new treatment, REGEND003, for people who have both type 2 diabetes and chronic kidney disease. The goal is to see if it can help manage these conditions together.
ShanghaiAges 30–75 - NCT07277413RecruitingPhase 1
Study of IDE892 for advanced solid tumors with MTAP deletion
This study tests a new drug called IDE892, alone or in combination, for people with advanced solid tumors that have a specific genetic change (MTAP deletion). The goal is to see if the drug is safe and whether it can shrink tumors.
Goodyear, ArizonaAges 18 years+ - NCT07270731RecruitingPhase 1
Study of a new medicine for type 2 diabetes and healthy volunteers
This study tests a new medicine (NNC9733-0001) to see how it works in healthy people and in people with type 2 diabetes. It helps researchers understand safety and how the body processes the drug.
NeussAges 18–64 - NCT06883682Recruiting
ECG sticker for checking blood sugar
This study tests a new way to measure blood sugar using an ECG (heart signal) sticker. It may help people with diabetes, chronic kidney disease, or those without diabetes monitor their glucose without finger sticks.
TaoyuanAges 18 years+ - NCT05008276Recruiting
Study of puberty, diabetes, and kidney stress in teens
This trial studies how puberty and blood sugar changes affect the kidneys in people with type 1 diabetes. It may help researchers understand early kidney risk and identify who needs closer monitoring.
Aurora, ColoradoAges 8–14 - NCT05966727Recruiting
Cholestyramine to lower stored pollutants in obese women
This study tests whether cholestyramine can lower blood levels of certain stored environmental pollutants (“POPs”) in women preparing for weight-loss surgery. If it works, it may help reduce pollutant levels that can build up in the body over time.
Nice, Alpes-MritimesAges 18–45 - NCT05759637Recruiting
Tests treatments for diabetes, weight, and high cortisol levels
This trial studies people who have type 2 diabetes and excess body weight, looking at how high cortisol (a stress hormone) may be involved. If you qualify, you may get a study treatment designed to improve diabetes and weight-related health by targeting cortisol-related pathways.
MilanAges 18–75 - NCT07276412Recruiting
Gamified health education program for primary school kids
This program uses a fun, game-like app called BELLOTEX-SALUD to teach healthy habits to elementary school children. It aims to see if this approach helps kids learn better about health.
Badajoz, BadajozAges 6–7 - NCT07269405Enrolling by invitation
Study to prevent high blood sugar in women with past gestational diabetes
This trial tests a program to help women who had diabetes during pregnancy and now have extra risk factors. It aims to prevent blood sugar problems after childbirth. You would join in the first months after delivery to get support and see if your blood sugar stays healthy.
ShatinAges 18–50 - NCT07277361Recruiting
Quality of life study for Fabry disease patients aged 65+
This study looks at the quality of life of people aged 65 and older with Fabry disease. It includes patients who are receiving specific treatment and those who are not, to compare their experiences.
Paris, FranceAges 65 years+ - NCT07271771RecruitingPhase 4
Denosumab for muscle and insulin in diabetes
This study tests whether denosumab, a medication that strengthens bones, can also improve muscle strength and insulin sensitivity in postmenopausal women with type 2 diabetes who take metformin.
AarhusAges 40 years+ - NCT07272837Recruiting
How semaglutide affects heart and muscle mass
This study looks at how semaglutide (Ozempic or Wegovy) changes heart muscle and body muscle. It may help people with type 2 diabetes or those taking the drug for weight loss understand if their heart is affected.
Edmonton, AlbertaAges 18–80 - NCT07275697RecruitingPhase 4
Weight loss drug and heart ablation study for AFib
This trial tests whether a weight loss medication (semaglutide) given before and after a first-time heart ablation procedure for atrial fibrillation can improve outcomes. It is for people who are overweight or obese and have certain related health conditions.
StockholmAges 18 years+ - NCT07277673Recruiting
Exercise plus talk therapy for impotence in men with metabolic syndrome
This trial tests if adding aerobic exercise to cognitive behavioral therapy (talk therapy) can help treat impotence in men who have metabolic syndrome and drink heavily.
Giza, DokkiAges 35–45 - NCT07272460Recruiting
Time-restricted eating for type 2 diabetes and weight health
This study is testing whether eating all your meals within a set window of time each day (time-restricted eating) can help improve blood sugar control and overall health in people with type 2 diabetes and excess weight.
Toronto, OntarioAges 18–75
Common questions
- How many hormones & metabolism clinical trials are recruiting?
- Clin2 is tracking 7,616 recruiting endocrinology & metabolism studies from the U.S. registry right now, out of 11,939 we cover in this area in total.
- What does “Hormones & metabolism” cover here?
- Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We group each study into hormones & metabolism based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a hormones & metabolism trial near me?
- Use the search to filter hormones & metabolism studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.